
    
      Methods: Twenty-eight subjects, who are clinically or radiologically diagnosed as having mild
      degree arthritic knee joint pain, are randomized into 3 groups; Groups A, B, C that contained
      100%, 80%, and 62.4% of fatty acid component with 12.5% of Cis-9-cetylmyristoleate (CMO), and
      control Group D (starch 100%). The pain intensity, functional disability state and change in
      the general status were assessed for a 12-week ingestion period.
    
  